PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction.
Ray U, Thirusangu P, Jin L, Xiao Y, Pathoulas CL, Staub J, Erskine CL, Dredge K, Hammond E, Block MS, Kaufmann SH, Bakkum-Gamez JN, Shridhar V.
Ray U, et al.
Oncogene. 2023 Sep;42(37):2725-2736. doi: 10.1038/s41388-023-02785-5. Epub 2023 Aug 7.
Oncogene. 2023.
PMID: 37550562
Free PMC article.